Literature DB >> 27484625

New Progress in Azole Compounds as Antimicrobial Agents.

Hui-Zhen Zhang1, Lin-Ling Gan, Hui Wang, Cheng-He Zhou2.   

Abstract

The increasing incidence of microbial resistance and newly emerging pathogens have become a serious challenge for public health. More and more efforts have been directed to the development of new antimicrobial agents with distinct mechanisms from the well-known classes of clinical drugs. The extensive clinical utilization of azole-based medicinal drugs has evoked numerous attentions, and their researches and developments have been a quite rapid developing and active highlight topic with an infinite space. Consideration of our researches on azole compounds and other literature in recent three years, this review scientifically reviewed the new progress of azole derivatives as antibacterial, antifungal, antitubercular and antiviral agents, including mono-nitrogen azoles (oxazoles, thiazoles and carbazoles), bis-nitrogen azoles (imidazoles, pyrazoles and benzimidazoles) and tri-nitrogen azoles (triazoles and benzotriazoles) as well as tetrazole derivatives. It was hoped that this review would be helpful for the design and development of highly efficient azole derivatives with high bioactivity and low toxicity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27484625     DOI: 10.2174/1389557516666160630120725

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Design, synthesis and biological evaluation of novel Schiff base-bridged tetrahydroprotoberberine triazoles as a new type of potential antimicrobial agents.

Authors:  Jun-Rong Duan; Han-Bo Liu; Ponmani Jeyakkumar; Lavanya Gopala; Shuo Li; Rong-Xia Geng; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

2.  Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration.

Authors:  Yuan Zhang; Guri L V Damu; Sheng-Feng Cui; Jia-Li Mi; Vijai Kumar Reddy Tangadanchu; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-06-15       Impact factor: 3.597

3.  Synthesis and Evaluation of Baylis-Hillman Reaction Derived Imidazole and Triazole Cinnamates as Antifungal Agents.

Authors:  Grady L Nelson; Michael J Williams; Shirisha Jonnalagadda; Mohammad A Alam; Gautam Mereddy; Joseph L Johnson; Sravan K Jonnalagadda
Journal:  Int J Med Chem       Date:  2018-10-16

Review 4.  The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.

Authors:  Jingxiang Zhang; Liping Li; Quanzhen Lv; Lan Yan; Yan Wang; Yuanying Jiang
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

5.  Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells.

Authors:  Claudio Luparello; Ilenia Cruciata; Andreas C Joerger; Cory A Ocasio; Rhiannon Jones; Raysa Khan Tareque; Mark C Bagley; John Spencer; Martin Walker; Carol Austin; Tiziana Ferrara; Pietro D Oca; Rossella Bellina; Rossella Branni; Fabio Caradonna
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 6.208

6.  Aloe-emodin derived azoles as a new structural type of potential antibacterial agents: design, synthesis, and evaluation of the action on membrane, DNA, and MRSA DNA isomerase.

Authors:  Xin-Yuan Liang; Narsaiah Battini; Yan-Fei Sui; Mohammad Fawad Ansari; Lin-Ling Gan; Cheng-He Zhou
Journal:  RSC Med Chem       Date:  2021-03-03

7.  Synthesis and Anticandidal Activity of New Imidazole-Chalcones.

Authors:  Derya Osmaniye; Betül Kaya Çavuşoğlu; Begüm Nurpelin Sağlık; Serkan Levent; Ulviye Acar Çevik; Özlem Atlı; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

8.  Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus.

Authors:  Di Li; Rammohan R Yadav Bheemanaboina; Narsaiah Battini; Vijai Kumar Reddy Tangadanchu; Xian-Fu Fang; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2018-08-01       Impact factor: 3.597

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.